Life expectancy and treatment response is currently very low for bladder cancer (BC) patients. The aim of the study is to a) define high-risk clinical characteristics and biomarker levels to identify patients requiring improved monitoring or earlier intervention b) define which patient populations currently have suboptimal outcomes and treatment responses c) what are the unmet medical needs concerning BC patients d) what are the current clinical outcomes and treatment patterns for BC.
